[144] CoreWeave, Inc. SEC Filing
Form 144 notice for CoreWeave, Inc. (CRWV) reports a proposed sale of 157,903 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $19,346,275.56, from a total of 370,470,348 shares outstanding. The approximate date of sale is 09/30/2025. The filing shows the securities to be sold consist of 100,000 founders shares acquired 11/13/2017 and 57,903 restricted stock units granted as compensation on 09/30/2025.
The notice also discloses a series of Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust during August and September 2025; the filing lists 12 separate 10b5-1 sale entries with individual gross proceeds shown for each trade. The filer certifies no undisclosed material adverse information and references compliance with Rule 144 and any applicable 10b5-1 plan.
Form 144 notice for CoreWeave, Inc. (CRWV) riporta una proposta di vendita di 157.903 azioni ordinarie tramite Morgan Stanley Smith Barney, con un valore di mercato aggregato di $19,346,275.56, su un totale di 370.470.348 azioni in circolazione. La data approssimativa di vendita è 30/09/2025. La presentazione indica che i titoli da vendere consistono in 100.000 azioni di fondatori acquisite il 13/11/2017 e 57.903 unità di azioni vincolate (RSU) concesse come compenso il 30/09/2025.
L’avviso rivela anche una serie di vendite ai sensi della Rule 10b5-1 da Brannin McBee e dal Brannin J. McBee 2022 IRR Trust nel periodo di agosto e settembre 2025; la pratica elenca 12 voci di vendita 10b5-1 distinte con i proventi lordi individuali indicati per ogni operazione. Il dichiarante certifica che non esistono informazioni materiali avverse non divulgate e fa riferimento al rispetto della Rule 144 e di eventuali piani 10b5-1 applicabili.
Form 144 notice for CoreWeave, Inc. (CRWV) informa sobre una propuesta de venta de 157,903 acciones comunes a través de Morgan Stanley Smith Barney, con un valor de mercado agregado de $19,346,275.56, de un total de 370,470,348 acciones en circulación. La fecha aproximada de venta es el 30/09/2025. El archivo indica que los valores a vender consisten en 100,000 acciones de fundadores adquiridas el 13/11/2017 y 57,903 unidades de acciones restringidas otorgadas como compensación el 30/09/2025.
El aviso también divulga una serie de ventas bajo la Regla 10b5-1 por Brannin McBee y el Brannin J. McBee 2022 IRR Trust durante agosto y septiembre de 2025; el archivo lista 12 entradas de venta 10b5-1 distintas con los ingresos brutos individuales mostrados para cada operación. El presentante certifica que no hay información adversa material no divulgada y hace referencia al cumplimiento con la Regla 144 y cualquier plan 10b5-1 aplicable.
CoreWeave, Inc. (CRWV)의 Form 144 공지는 Morgan Stanley Smith Barney를 통해 157,903 주의 보통주 매각 제안을 보고하며, 총 시장가치가 $19,346,275.56, 발행주식 총수는 370,470,348주입니다. 매각 예상일은 2025-09-30이며, 매도 대상 증권은 2017-11-13에 취득한 100,000주 창립자 주식과 2025-09-30에 부여된 57,903주의 제한 주식 유닛(RSU)으로 구성됩니다.
또한 이 공지는 Brannin McBee 및 Brannin J. McBee 2022 IRR Trust가 2025년 8월~9월에 걸쳐 행한 Rule 10b5-1 매매를 공개합니다; 제출물은 각 거래에 대한 개별 총수익이 기재된 12건의 10b5-1 매매 항목을 나열합니다. 신고자는 비공개로 공개되지 않은 중대한 악재 정보가 없음을 인증하고 Rule 144 및 적용 가능한 10b5-1 계획의 준수를 언급합니다.
Avis Form 144 pour CoreWeave, Inc. (CRWV) signale une proposition de vente de 157 903 actions ordinaires par l’intermédiaire de Morgan Stanley Smith Barney, pour une valeur marchande globale de 19 346 275,56 $, sur un total de 370 470 348 actions en circulation. La date de vente approximative est le 30/09/2025. Le dossier indique que les titres à vendre se composent de 100 000 actions des fondateurs acquises le 13/11/2017 et de 57 903 unités d’actions restreintes accordées en tant que compensation le 30/09/2025.
L’avis divulge également une série de ventes selon la règle 10b5-1 par Brannin McBee et le Brannin J. McBee 2022 IRR Trust durant août et septembre 2025; le dossier répertorie 12 entrées de vente 10b5-1 distinctes avec les gains bruts individuels indiqués pour chaque transaction. Le déposant certifie qu’il n’y a pas d’informations matérielles défavorables non divulguées et fait référence au respect de la Rule 144 et de tout plan 10b5-1 applicable.
Form 144 Mitteilung für CoreWeave, Inc. (CRWV) meldet einen vorgeschlagenen Verkauf von 157.903 Stammaktien über Morgan Stanley Smith Barney, mit einem aggregierten Marktwert von $19,346,275.56, aus insgesamt 370.470.348 ausstehenden Aktien. Das voraussichtliche Verkaufsdatum ist der 30.09.2025. Die Einreichung zeigt, dass die zu verkaufenden Wertpapiere aus 100.000 Gründeraktien bestehen, die am 13.11.2017 erworben wurden, und aus 57.903 Restricted Stock Units, die am 30.09.2025 als Vergütung gewährt wurden.
Die Mitteilung offenbart außerdem eine Reihe von Verkäufen nach Rule 10b5-1 durch Brannin McBee und den Brannin J. McBee 2022 IRR Trust im August und September 2025; die Einreichung listet 12 separate 10b5-1-Verkaufspositionen mit den jeweiligen Bruttoerlösen auf. Der Einreicher bestätigt, dass keine unbekannten wesentlichen nachteiligen Informationen vorliegen, und verweist auf die Einhaltung von Rule 144 und etwaigen anwendbaren 10b5-1-Plänen.
إشعار Form 144 لشركة CoreWeave, Inc. (CRWV) يورد اقتراح بيع لـ 157,903 سهماً عادياً من خلال مورجان ستانلي سميث بارني، بقيمة سوقية كلية قدرها $19,346,275.56، من إجمالي 370,470,348 سهماً قائماً. تاريخ البيع التقريبي هو 30/09/2025. يُظهر الملف أن الأوراق المالية المراد بيعها تتكون من 100,000 سهم مؤسس مَشترى في 13/11/2017 و 57,903 وحدة أسهم مقيدة مُمنوحة كتعويض في 30/09/2025.
كما يكشف الإشعار عن سلسلة من مبيعات Rule 10b5-1 من قبل Brannin McBee وصندوق Brannin J. McBee 2022 IRR Trust خلال أغسطس وسبتمبر 2025؛ يدرج الملف 12 إدخالاً منفصلاً لمبيعات 10b5-1 مع العوائد الإجمالية لكل صفقة. يؤكد المقدم عدم وجود معلومات سلبية مادية غير مُعلنة ويشير إلى الالتزام بـ Rule 144 وأية خطة 10b5-1 سارية.
CoreWeave, Inc.（CRWV）Form 144 通知 显示拟通过摩根士丹利史密斯巴尼出售 157,903 股普通股，交易总市值为 $19,346,275.56，发行在外总股数为 370,470,348 股。预计出售日期为 2025-09-30。文件显示拟出售的证券包括于 2017-11-13 获得的 100,000 股创始人股票，以及在 2025-09-30 授予的 57,903 股受限股票单位（RSU）作为补偿。
通知还披露 Brannin McBee 及 Brannin J. McBee 2022 IRR Trust 在 2025 年 8 月至 9 月期间的多笔 Rule 10b5-1 交易；备案列出 12 条独立的 10b5-1 交易条目及每笔交易的毛收入。申报人证明不存在未披露的重大不利信息，并提及遵守 Rule 144 及任何适用的 10b5-1 计划。
- Transparent disclosure of the proposed sale amount (157,903 shares) and aggregate market value ($19,346,275.56)
- Breakout of acquisition types provided: 100,000 founders shares (11/13/2017) and 57,903 RSUs (09/30/2025)
- Broker identified for the transaction: Morgan Stanley Smith Barney, indicating an institutional execution channel
- Historical 10b5-1 trades listed (12 entries), providing visibility into recent insider selling activity
- Substantial insider selling activity shown by multiple 10b5-1 transactions in Aug–Sep 2025, including individual gross proceeds up to $49,435,537.50
- Filing presents insider liquidity which investors may interpret unfavorably despite being routine and pre-planned
Insights
TL;DR: Routine insider sale notice showing planned sale of 157,903 shares and multiple recent 10b5-1 transactions; material as a disclosure but not a financial-performance event.
The Form 144 is a standard disclosure of an intended sale by an insider or related account rather than a company operational update. Key items are the number of shares proposed for sale (157,903), the broker (Morgan Stanley Smith Barney), and the split between founders shares and recently issued restricted stock units. The inclusion of 12 recent 10b5-1 sales with explicit gross proceeds provides transparency on prior dispositions. For investors this is a governance and liquidity signal rather than an earnings or credit event; it documents insider selling activity but does not in itself indicate company performance.
TL;DR: Filing demonstrates compliance with disclosure rules and use of 10b5-1 plans; notable for frequency and magnitude of prior insider sales.
This submission meets Rule 144 disclosure requirements by identifying the class, amount, acquisition dates, and nature of acquisition (founders shares and RSUs). The presence of multiple 10b5-1 sale records in August–September 2025 indicates pre-arranged trading plans were executed, which supports procedural compliance. The statement that the signer is unaware of undisclosed material adverse information is included as required. From a governance perspective, the document is routine but worth monitoring due to numerous recent insider dispositions reflected in the filing.
Form 144 notice for CoreWeave, Inc. (CRWV) riporta una proposta di vendita di 157.903 azioni ordinarie tramite Morgan Stanley Smith Barney, con un valore di mercato aggregato di $19,346,275.56, su un totale di 370.470.348 azioni in circolazione. La data approssimativa di vendita è 30/09/2025. La presentazione indica che i titoli da vendere consistono in 100.000 azioni di fondatori acquisite il 13/11/2017 e 57.903 unità di azioni vincolate (RSU) concesse come compenso il 30/09/2025.
L’avviso rivela anche una serie di vendite ai sensi della Rule 10b5-1 da Brannin McBee e dal Brannin J. McBee 2022 IRR Trust nel periodo di agosto e settembre 2025; la pratica elenca 12 voci di vendita 10b5-1 distinte con i proventi lordi individuali indicati per ogni operazione. Il dichiarante certifica che non esistono informazioni materiali avverse non divulgate e fa riferimento al rispetto della Rule 144 e di eventuali piani 10b5-1 applicabili.
Form 144 notice for CoreWeave, Inc. (CRWV) informa sobre una propuesta de venta de 157,903 acciones comunes a través de Morgan Stanley Smith Barney, con un valor de mercado agregado de $19,346,275.56, de un total de 370,470,348 acciones en circulación. La fecha aproximada de venta es el 30/09/2025. El archivo indica que los valores a vender consisten en 100,000 acciones de fundadores adquiridas el 13/11/2017 y 57,903 unidades de acciones restringidas otorgadas como compensación el 30/09/2025.
El aviso también divulga una serie de ventas bajo la Regla 10b5-1 por Brannin McBee y el Brannin J. McBee 2022 IRR Trust durante agosto y septiembre de 2025; el archivo lista 12 entradas de venta 10b5-1 distintas con los ingresos brutos individuales mostrados para cada operación. El presentante certifica que no hay información adversa material no divulgada y hace referencia al cumplimiento con la Regla 144 y cualquier plan 10b5-1 aplicable.
CoreWeave, Inc. (CRWV)의 Form 144 공지는 Morgan Stanley Smith Barney를 통해 157,903 주의 보통주 매각 제안을 보고하며, 총 시장가치가 $19,346,275.56, 발행주식 총수는 370,470,348주입니다. 매각 예상일은 2025-09-30이며, 매도 대상 증권은 2017-11-13에 취득한 100,000주 창립자 주식과 2025-09-30에 부여된 57,903주의 제한 주식 유닛(RSU)으로 구성됩니다.
또한 이 공지는 Brannin McBee 및 Brannin J. McBee 2022 IRR Trust가 2025년 8월~9월에 걸쳐 행한 Rule 10b5-1 매매를 공개합니다; 제출물은 각 거래에 대한 개별 총수익이 기재된 12건의 10b5-1 매매 항목을 나열합니다. 신고자는 비공개로 공개되지 않은 중대한 악재 정보가 없음을 인증하고 Rule 144 및 적용 가능한 10b5-1 계획의 준수를 언급합니다.
Avis Form 144 pour CoreWeave, Inc. (CRWV) signale une proposition de vente de 157 903 actions ordinaires par l’intermédiaire de Morgan Stanley Smith Barney, pour une valeur marchande globale de 19 346 275,56 $, sur un total de 370 470 348 actions en circulation. La date de vente approximative est le 30/09/2025. Le dossier indique que les titres à vendre se composent de 100 000 actions des fondateurs acquises le 13/11/2017 et de 57 903 unités d’actions restreintes accordées en tant que compensation le 30/09/2025.
L’avis divulge également une série de ventes selon la règle 10b5-1 par Brannin McBee et le Brannin J. McBee 2022 IRR Trust durant août et septembre 2025; le dossier répertorie 12 entrées de vente 10b5-1 distinctes avec les gains bruts individuels indiqués pour chaque transaction. Le déposant certifie qu’il n’y a pas d’informations matérielles défavorables non divulguées et fait référence au respect de la Rule 144 et de tout plan 10b5-1 applicable.
Form 144 Mitteilung für CoreWeave, Inc. (CRWV) meldet einen vorgeschlagenen Verkauf von 157.903 Stammaktien über Morgan Stanley Smith Barney, mit einem aggregierten Marktwert von $19,346,275.56, aus insgesamt 370.470.348 ausstehenden Aktien. Das voraussichtliche Verkaufsdatum ist der 30.09.2025. Die Einreichung zeigt, dass die zu verkaufenden Wertpapiere aus 100.000 Gründeraktien bestehen, die am 13.11.2017 erworben wurden, und aus 57.903 Restricted Stock Units, die am 30.09.2025 als Vergütung gewährt wurden.
Die Mitteilung offenbart außerdem eine Reihe von Verkäufen nach Rule 10b5-1 durch Brannin McBee und den Brannin J. McBee 2022 IRR Trust im August und September 2025; die Einreichung listet 12 separate 10b5-1-Verkaufspositionen mit den jeweiligen Bruttoerlösen auf. Der Einreicher bestätigt, dass keine unbekannten wesentlichen nachteiligen Informationen vorliegen, und verweist auf die Einhaltung von Rule 144 und etwaigen anwendbaren 10b5-1-Plänen.
FAQ
What shares does the Form 144 for CRWV propose to sell?
When is the approximate sale date listed on the Form 144?
What is the composition of the shares being sold according to the filing?
Does the filing show prior insider sales?
Who is the broker handling the proposed sale?
